EEMRX Performance — MFS Emerging Markets Equity Research Fund, Class C
Data updated: 2026-10-13
EEMRX returned +19.03% year to date and +33.64% over one year to Jul 2026. Annualised returns are +16.25% over 3 years and +6.39% over 5 years. The fund trailed its Emerging Markets Equity category average: $100 invested three years ago grew to $157, against $164 for the category, and to $134 over one year, against $134. Volatility over the past three years was 14.70% a year. In the 12 months to Jul 2026 the fund took in a net $688K, and assets reached $5.46M.
EEMRX Growth of $100
What $100 invested in MFS Emerging Markets Equity Research Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | EEMRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $134 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $157 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $136 | $143 |
| Since data start (Feb 2021 – Jul 2026) | $125 | $148 |
EEMRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +19.03% |
| 1 year | +33.64% |
| 3 years (annualised) | +16.25% |
| 5 years (annualised) | +6.39% |
EEMRX Annual Returns
Calendar-year total returns of MFS Emerging Markets Equity Research Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +19.03% |
| 2025 | +29.60% |
| 2024 | +6.21% |
| 2023 | +8.19% |
| 2022 | −23.05% |
| 2021 (Feb–Dec) | −8.16% |
EEMRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.9% | +3.7% | −9.0% | +12.3% | +8.2% | −0.8% | −3.0% | — | — | — | — | — |
| 2025 | +1.8% | −1.0% | +1.0% | +1.8% | +4.1% | +5.0% | +2.0% | +2.0% | +5.1% | +4.1% | −1.6% | +2.2% |
| 2024 | −4.4% | +3.4% | +2.6% | +0.8% | +0.5% | +2.6% | +1.7% | +1.0% | +5.5% | −4.7% | −2.6% | +0.3% |
| 2023 | +9.1% | −6.4% | +3.8% | −0.1% | −2.8% | +5.3% | +4.2% | −6.7% | −2.2% | −3.2% | +4.9% | +3.5% |
| 2022 | −1.3% | −7.8% | −2.6% | −6.0% | +1.4% | −5.6% | −0.5% | −1.9% | −11.0% | −4.6% | +17.5% | −1.0% |
| 2021 | — | −5.4% | −0.9% | +0.9% | +3.4% | −0.7% | −5.3% | +3.2% | −4.2% | +2.1% | −3.7% | +2.9% |
EEMRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.70%
- 3-year Sharpe ratio: 0.80 (vs 4.5% risk-free rate)
- Best month: +12.33% (Apr 2026)
- Worst month: −8.99% (Mar 2026)
EEMRX Fund Flows
Monthly money in and out of MFS Emerging Markets Equity Research Fund, from SEC Form N-PORT.
- 12-month net flow: $688K
- 12-month gross sales (incl. reinvestments): $741K
- Sales ÷ redemptions: 14.10×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $13K | $158 | $13K |
| Jun 2026 | $174K | $0 | $174K |
| May 2026 | $24K | $0 | $24K |
| Apr 2026 | $6K | $2K | $4K |
| Mar 2026 | $5K | $0 | $5K |
| Feb 2026 | $179K | $0 | $179K |
| Jan 2026 | $65K | $165 | $65K |
| Dec 2025 | $76K | $2K | $74K |
| Nov 2025 | $177K | $9K | $168K |
| Oct 2025 | $20K | $21K | −$1K |
| Sep 2025 | $2K | $1 | $2K |
| Aug 2025 | $227 | $19K | −$18K |
EEMRX Assets Under Management
Net assets of MFS Emerging Markets Equity Research Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $5.46M |
| 2026-04-30 | $5.04M |
| 2026-01-31 | $4.56M |
| 2025-10-31 | $3.96M |
| 2025-07-31 | $3.58M |
| 2025-04-30 | $3.20M |
| 2025-01-31 | $3.11M |
| 2024-10-31 | $3.12M |
| 2024-07-31 | $3.10M |
| 2024-04-30 | $2.84M |
| 2024-01-31 | $2.67M |
| 2023-10-31 | $2.52M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.